ArticleFrontiers in oncology2023

Development and validation of an inflammatory response-related signature in triple negative breast cancer for predicting prognosis and immunotherapy.

Yangyang Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.